Literature DB >> 17261067

20S-protopanaxadiol-induced programmed cell death in glioma cells through caspase-dependent and -independent pathways.

Guo-Yu Liu1, Xuexian Bu, Hang Yan, William W-G Jia.   

Abstract

20S-Protopanaxadiol (1) is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponins. In the present study, 1 was used to induce cytotoxicity for two human glioma cell lines, SF188 and U87MG. For the SF188 cells, 1 activated caspases-3, -8, -7, and -9 within 3 h and induced rapid apoptosis, which could be partially inhibited by a general caspase blocker and completely abolished when the caspase blocker was used in combination with an antioxidant. Compound 1 also induced cell death in U87MG cells but did not activate any caspases in these cells. Monodansylcadaverine staining showed that 1 induced dramatic autophagy in both cell lines. Elevated levels of superoxide anion in both cells and reduced levels of phosphorylated Akt in U87MG cells were also demonstrated. These results showed that 20S-protopanaxadiol (1) induces different forms of programmed cell death, including both typical apoptosis and autophagy through both caspase-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261067     DOI: 10.1021/np060313t

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  11 in total

1.  The continuing search for antitumor agents from higher plants.

Authors:  Li Pan; Heebyung Chai; A Douglas Kinghorn
Journal:  Phytochem Lett       Date:  2010-03-12       Impact factor: 1.679

Review 2.  Discovery of new anticancer agents from higher plants.

Authors:  Li Pan; Hee-Byung Chai; Alan Douglas Kinghorn
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

3.  Cell-type-specific regulation of raft-associated Akt signaling.

Authors:  Y Liu; G Yang; X Bu; G Liu; J Ding; P Li; W Jia
Journal:  Cell Death Dis       Date:  2011-04-14       Impact factor: 8.469

4.  The apoptotic effect of D Rhamnose β-hederin, a novel oleanane-type triterpenoid saponin on breast cancer cells.

Authors:  Lin Cheng; Tian-Song Xia; Yi-Fen Wang; Wenbin Zhou; Xiu-Qing Liang; Jin-Qiu Xue; Liang Shi; Ying Wang; Qiang Ding
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

5.  Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.

Authors:  Xin Jin; Zhen-hai Zhang; E Sun; Xiao-bin Tan; Song-lin Li; Xu-dong Cheng; Ming You; Xiao-bin Jia
Journal:  Int J Nanomedicine       Date:  2013-02-12

6.  Ginsenoside compound K induces apoptosis in nasopharyngeal carcinoma cells via activation of apoptosis-inducing factor.

Authors:  Carmen Ka-Man Law; Hoi-Hin Kwok; Po-Ying Poon; Chi-Chiu Lau; Zhi-Hong Jiang; William Chi-Shing Tai; Wendy Wen-Luan Hsiao; Nai-Ki Mak; Patrick Ying-Kit Yue; Ricky Ngok-Shun Wong
Journal:  Chin Med       Date:  2014-04-02       Impact factor: 5.455

7.  Identification of Human UDP-Glucuronosyltransferase 1A4 as the Major Isozyme Responsible for the Glucuronidation of 20(S)-Protopanaxadiol in Human Liver Microsomes.

Authors:  Jia Li; Chunyong He; Lianxiang Fang; Li Yang; Zhengtao Wang
Journal:  Int J Mol Sci       Date:  2016-03-09       Impact factor: 5.923

Review 8.  Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites.

Authors:  Xiao-Jia Chen; Xiao-Jing Zhang; Yan-Mei Shui; Jian-Bo Wan; Jian-Li Gao
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-30       Impact factor: 2.629

9.  20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway.

Authors:  Hong Zhang; Hua-Li Xu; Yu-Chen Wang; Ze-Yuan Lu; Xiao-Feng Yu; Da-Yun Sui
Journal:  Int J Mol Sci       Date:  2018-04-02       Impact factor: 5.923

10.  A 20(S)-protopanaxadiol derivative PPD12 reverses ABCB1-mediated multidrug resistance with oral bioavailability and low toxicity.

Authors:  Shunfeng Wei; Wantao Chen; Lihong Hu; Jinsong Pan; Xu Wang
Journal:  Oncol Lett       Date:  2018-08-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.